Matricelf

Biotechnology company founded in 2019 in Israel, specializing in regenerative medicine platforms. Matricelf Ltd focuses on developing innovative treatments for medical conditions such as spinal cord injuries and age-related macular degeneration, differentiating itself through its cutting-edge technology and research. The company's primary target demographic includes patients suffering from these conditions and medical professionals seeking advanced therapeutic solutions.